FDA Approves Generic Valsartan

March 13, 2019

The U.S. Food and Drug Administration (FDA) on March 12 approved a new generic of Diovan (valsartan).

“The FDA prioritized the review of this drug application to help relieve the recent shortage of this critical medicine as a result of multiple recalls of generic valsartan products from several manufacturers due to the finding that certain lots of valsartan and other ARB medicines contain nitrosamine impurities,” the agency said in a press release.

Read the press release.